EPO Patents = 5

Forward Citations = 0

Loading Chart...

2 inventors (with patents filed for the assignee):

Giangiacomo Torri (5 out of 28 patents)

Annamaria Naggi (5 out of 19 patents)

5 patents: Sort by Forward Citations

1. 11370848 - Carboxylated derivatives of glycosaminoglycans and use as drugs (2022-06-28),

2. 11332548 - Carboxylated derivatives of glycosaminoglycans and use as drugs (2022-05-17),

3. 11248063 - Derivatives of N-desulfated glycosaminoglycans and use as drugs (2022-02-15),

4. 10875936 - Derivatives of N-desulfated glycosaminoglycans and use as drugs (2020-12-29),

5. 10822430 - Carboxylated derivatives of glycosaminoglycans and use as drugs (2020-11-03),

Company Overview

Novahealth Biosystems, LLC is a leading biotechnology company specializing in innovative diagnostic solutions for various healthcare needs. Our cutting-edge products and services aim to improve patient outcomes and streamline clinical processes. With a dedicated team of experts and state-of-the-art technologies, we are committed to revolutionizing the healthcare industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#4 in Waunakee, WI

#1,089 in Wisconsin

#51,620 in US

Waunakee, WI, United States of America

Novahealth Biosystems, LLC

Forward Citations = 0

2 inventors:

Giangiacomo Torri (5 out of 28 patents)

Annamaria Naggi (5 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novahealth Biosystems, LLC. Retrieved from https://idiyas.com/company/novahealth-biosystems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]